The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.

The First in China! BLA Submitted for Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026 HONG KONG ...

Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.

subunit or recombinant protein vaccines (such as those against diphtheria, pertussis, tetanus, hepatitis B virus and flu), which require multiple doses and regular boosting, live attenuated ...

Hexaplex' Vaccine Aims to Boost Flu Protection Feb. 26, 2024 — A research team has developed a recombinant protein flu vaccine candidate. It utilizes a nanoliposome vaccine platform that ...

The poultry medicine/pharmaceuticals market valued at US$ 4.73 billion in 2023, is forecasted to grow at a robust CAGR of 5.9%, reaching ...

recombinant protein and DNA vaccines, as well as the use of attenuated vaccines. Data regarding the correlates of protection, animal models and the available evidence regarding potential vaccine ...

the recombinant vaccines and the live attenuated vaccines. The killed vaccines are prepared from dead or inactivated organisms. They usually have side effects that occur on the same day with pain ...

"Although oral rehydration therapy and live-attenuated rotavirus vaccines have helped reduce ... as well as novel genetic recombinant strains generated by a reverse genetics system, the team ...